Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

February 14, 2024

Invitation to Immunovia’s Q4 presentation

Read press release
January 31, 2024

Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs

Read press release
January 4, 2024

Immunovia announces financial calendar for financial year 2024

Read press release
November 21, 2023 | REGULATORY

Bulletin from the extraordinary general meeting in Immunovia AB

Read press release
November 9, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-September 2023

Read press release
November 7, 2023

Immunovia successfully completes discovery phase of next-generation test development

Read press release
November 2, 2023

Invitation to Immunovia’s Q3 presentation

Read press release
October 27, 2023 | REGULATORY

CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)

Read press release
October 3, 2023 | REGULATORY

Nomination Committee appointed for Immunovia AB (Publ)

Read press release
August 30, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-June 2023

Read press release
August 23, 2023

Invitation to Immunovia’s Q2 presentation

Read press release
July 19, 2023

Immunovia announces updated financial calendar

Read press release
1 2 3 4 28